INTERNATIONAL PATENT: GENECENTRIC THERAPEUTICS, INC. FILES APPLICATION FOR "METHOD FOR ASSESSING MICROSATELLITE INSTABILITY AND HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY IN CANCER"

GENEVA, Oct. 15 -- GENECENTRIC THERAPEUTICS, INC. (6 Davis Drive, Suite 146Durham, North Carolina 27709) filed a patent application (PCT/US2025/022005) for "METHOD FOR ASSESSING MICROSATELLITE INSTABILITY AND HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY IN CANCER" on Mar 28, 2025. With publication no. WO/2025/212419, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAYHEW, Gregory (c/o GeneCentric Therapeutics, Inc.6 Davis Drive, Suite 146Durham, North Carolina 27709), PAPPAN, Kirk (c/o GeneCentric Therapeutics, Inc.6 Davis ...